TI
GILD icon

Truepoint Inc’s Gilead Sciences GILD Stock Holding History

Truepoint Inc’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,440
Closed -$279K – 176
2023
Q4 		$279K Buy
+3,440
New +$268K 0.01% 183
2017
Q4 		– Sell
-700
Closed -$57K – 99
2017
Q3 		$57K Sell
700
-1,994
-74% -$152K 0.01% 99
2017
Q2 		$204K Buy
+2,694
New +$179K 0.02% 98

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Truepoint Inc's GILD Position: Q1 2024 in Review

Truepoint Inc sold out of Gilead Sciences (GILD) in Q1 2024, closing a stake of 3,440 shares — an estimated $279K sold.

Truepoint Inc first reported a position in GILD in Q2 2017 and held it in 3 quarters. The position peaked at $279K in Q4 2023. 1,721 funds tracked by Wall St. Rank hold GILD as of Q1 2024.

  • Truepoint Inc reported no remaining Gilead Sciences position as of Q1 2024 after selling out during the quarter.
  • Truepoint Inc sold 3,440 Gilead Sciences shares in Q1 2024, an estimated $279K.
  • Truepoint Inc first reported a position in Gilead Sciences in Q2 2017 and held it in 3 quarters.
  • Truepoint Inc's Gilead Sciences position peaked at $279K in Q4 2023.
  • 1,721 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2024.

Based on Truepoint Inc's 13F filing for Q1 2024, filed 9 May 2024.